{
    "2020-03-16": [
        [
            {
                "time": "",
                "orginal_text": "贝达药业定增疑云",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "定增",
                        "疑云"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "orginal_text": "【中信建投医药 | 行业周报】海外疫情进展迅速，中国制造优势凸显",
                "features": {
                    "keywords": [
                        "中信建投",
                        "医药",
                        "行业周报",
                        "海外疫情",
                        "中国制造",
                        "优势凸显"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}